Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma

Clinical trial NCT00937495 · COMPLETED

Trial details

NCT number: NCT00937495
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma

Start date: 2009-06-01
Primary completion: 2010-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.